Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02688114 · ClinicalTrials.gov registry record · NA
Healing of the Esophageal Mucosa After RFA of Barrett's Esophagus
A NA study, sponsored by Dallas VA Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT02688114 is a NA study that has completed, run by Dallas VA Medical Center. The registered enrollment target is 8 participants.
The verdict
NCT02688114, a NA study, has completed, sponsored by Dallas VA Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
Radiofrequency ablation (RFA) is a mainstay of treatment for patients who have Barrett's esophagus (BE) with dysplasia. For unclear reasons, Barrett's esophagus recurs after successful RFA treatment in approximately 1/3 of patients. The aim of this study is to characterize the healing process of the esophageal mucosa, histologically and at the molecular level, after RFA for non-dysplastic and dysplastic Barrett's esophagus.
Interventions
- PROCEDURE Radiofrequency ablation
- PROCEDURE Baseline surveillance endoscopy
- PROCEDURE Follow up endoscopy 1
- PROCEDURE Follow up endoscopy 2
- PROCEDURE Follow up endoscopy 3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2017-10-18 |
| Est. Completion | 2020-01-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02688114
The ClinicalTrials.gov registry entry for NCT02688114 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dallas VA Medical Center, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Radiofrequency ablation is the first listed.
NCT02688114 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02688114 about?
NCT02688114 is a clinical study titled "Healing of the Esophageal Mucosa After RFA of Barrett's Esophagus". Radiofrequency ablation (RFA) is a mainstay of treatment for patients who have Barrett's esophagus (BE) with dysplasia. For unclear reasons, Barrett's esophagus recurs after successful RFA treatment in approximately 1/3 of patients. The aim of this study is to characterize the healing process of the...
What is the current status of trial NCT02688114?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2017-10-18. Estimated completion is 2020-01-29.
What interventions are being tested in trial NCT02688114?
The interventions under investigation include: Radiofrequency ablation (PROCEDURE), Baseline surveillance endoscopy (PROCEDURE), Follow up endoscopy 1 (PROCEDURE), Follow up endoscopy 2 (PROCEDURE), Follow up endoscopy 3 (PROCEDURE).
Who is sponsoring clinical trial NCT02688114?
This trial is sponsored by Dallas VA Medical Center, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.